Instead of defending the body against lymphoma, special immune cells sometimes have the opposite effect. The cancer reprograms the dendritic cells to promote lymphoma tumor growth. Researchers at the Max Delbrück Center for Molecular Medicine in the...

An international research team has succeeded in stopping the growth of malignant melanoma by reactivating a protective mechanism that prevents tumor cells from dividing. The team used chemical agents to block the enzymes responsible for erasing...

The UN Global Compact is the world's largest and most important initiative for responsible corporate governance, involving more than 12,800 companies and organizations from more than 160 countries, 454 of them from Germany. The vision of this United...

The IT specialist for medicine, Professor Sylvia Thun, will be the new Director for eHealth and Interoperability at Berlin Institute of Health (BIH). The physician and qualified engineer is an expert in national and international IT standards in the...

• MOLOGEN to receive a EUR 3 million initial payment as well as a EUR 2 million equity investment • Milestone payments of above EUR 100 million and double digit royalties on net sales • Strong support for global development program of lefitolimod,...

Research License Agreement on Unique Technology to Assess Drug Effects on the Immune System in Vitro.

A study conducted by the 3.works institute from Düsseldorf confirms, that KNAUER is one of the companies in Germany with the best employer ratings. The results of the study will be published in cooperation with the renowned ZEIT publishing group.

Twenty-five years ago, an unusual inherited form of high blood pressure was first described in an Australian family. Its genetic cause, however, had remained elusive. Using modern sequencing methods, an international research team led by BIH Johanna...

Startupbootcamp Digital Health Berlin is now entering its 3rd cycle, and is one of the most serious health accelerators in the continent. How, you ask?

Regulation of adipose tissue metabolism as a potential treatment for heart failure